Related Experiment Video
Updated: Jul 25, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Bone Density Reduction and Its Associated Factors in Kidney Transplant Recipients: A Cross-Sectional Study
B Gheiasi1, M Hadavi1, R Asadzadeh1
1Department of Internal Medicine, School of Medicine, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Kidney transplant recipients often experience decreased bone mineral density (BMD). Prednisolone use, age, and vitamin D levels are key factors influencing osteoporosis risk in these patients.
Area of Science:
- Nephrology
- Endocrinology
- Orthopedics
Background:
- Decreased bone mineral density (BMD) is a common complication following kidney transplantation.
- Factors contributing to BMD reduction are numerous, but research findings remain inconsistent.
Purpose of the Study:
- To determine the prevalence of reduced BMD in kidney transplant recipients.
- To identify factors associated with BMD reduction in this patient population.
Main Methods:
- A study included 69 kidney transplant recipients between 2016-2018.
- Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry.
- Statistical analyses included logistic regression to identify risk factors.
Main Results:
- Overall osteoporosis prevalence was 38% in the femur and 32% in the lumbar spine.
- In younger patients (<50 years), osteoporosis was linked to vitamin D levels and sex.
- In older patients (>50 years), osteoporosis risk increased with age and duration of prednisolone use.
Conclusions:
- Prednisolone consumption is a significant factor in BMD reduction post-kidney transplant.
- Regular BMD monitoring and minimizing prednisolone dosage are crucial for prevention.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

